Article
Hemochromatosis (HFE) gene mutations and peripheral neuropathy during antiretroviral therapy.
AIDS (London, England) - 13 Jul 2006
Kallianpur Asha R, Hulgan Todd, Canter Jeffrey A, Ritchie Marylyn D, Haines Jonathan L, Robbins Gregory K, Shafer Robert W, Clifford David B, Haas David W
Abstract excerpt
OBJECTIVE: Peripheral neuropathy (PN) often complicates nucleoside reverse transcriptase inhibitor (NRTI) therapy of HIV infection and may involve mitochondrial dysfunction. Since iron deficiency is associated with some types of PN, and iron is essential for mitochondrial function, we tested the hypothesis that hemochromatosis (HFE) gene mutations influence susceptibility to NRTI-induced PN. DESIGN: Case-control...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
